Nurix Therapeutics, Inc. (NRIX)
NGM – Real Time Price. Currency in USD
26.47
+0.51 (1.96%)
Market open: Aug 12, 2026, 3:17 PM EDT
25.96
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
26.47
+0.51 (1.96%)
Market open: Aug 12, 2026, 3:17 PM EDT
25.96
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $67.7M significantly exceed its total debt $58.1M, ensuring strong financial flexibility
Total current assets $456.5M exceed Total current liabilities $72.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$98.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.34 | 6.05 | 10 | |
| Quick ratio | 6.34 | 5.63 | 10 | |
| Debt to Equity | 0.14 | 0.30 | 9.0 | |
| Debt to Assets | 0.11 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 39M | 77M | 55M | 84M | 37M |
| Gross Profit | 28M | 63M | 38M | 65M | 20M |
| Operating Income | -184M | -155M | -213M | -286M | -361M |
| Net Income | -180M | -144M | -194M | -264M | -341M |
| EBITDA | -173M | -141M | -197M | -267M | -344M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 185.35 | 42.63 | 10 |
| Next quarter | 89.14 | 82.57 | 10 |
| Current year | -24.11 | 11.97 | 4.0 |
| Next year | 64.15 | 26 | 10 |
| Weighted average score | 8.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 44.64 | -2.7 | -2.52 | -35.01 | 3.3 |
| Y/Y | -79.46 | -105.99 | -55.76 | -49.62 | 1.0 |
| 3y average | 41.37 | -16.95 | 4.67 | -33.2 | 4.0 |
| 5y average | 44.18 | -55.15 | -4.15 | -406.76 | 3.3 |
| Weighted average score | 2.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |